Abiopharma

Une nouvelle étude de MetLife révèle un « déficit de confiance » de 72 % quant à la capacité à se remettre des épreuves de la vie

Eine neue Studie von MetLife deckt eine „Vertrauenslücke“ von 72 % hinsichtlich der Fähigkeit auf, Rückschläge im Leben zu überwinden

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

VCI Global Strengthens Capital Alignment Following Premium Warrant Conversion by Institutional Investor

Q2 Metals Commences Summer Drill Program and Advances Toward PEA on the Cisco Lithium Project in Quebec, Canada

Wingstop Elevates its Summer Flavor Game with New Sweet Heat Chamoy Featuring Tajín

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

PHINIA Inc. to Report Q2 2026 Earnings

OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms